Den norske patologforening

Doktorgrader

Stavanger

10. november 2011

2014 PHD. OK MÅLFRID MANGRUD. IDENTIFICATION OF PATIENTS WITH HIGH AND LOW PROGRESSION OF UROTHELIAL CARCINOMA OF THE URINARY BLADDER STAGE Ta AND T1. SUPERVISOR: EMIEL AM JANSSEN, JAN PA BAAK.

2013 PHD. KRISTIN JONSDOTTIR. COMPARISON OF THE PROGNOSTIC VALUE OF microRNA, GENE-EXPRESSION SIGNATURES AND PROLIFERATION IN EARLY NODE-NEGATIVE BREAST CANCER. SUPERVISOR: EMIEL AM JANSSEN, JAN PA BAAK

2013 PHD WEIWEI FENG. DIAGNOSTIC , PROGNOSTIC AND THERAPEUTIC ASPECTS OF ENDOMETRIAL STROMAL SARCOMAS, LOW GRADE AND UNDIFFERENTIATED ENDOMETRIAL SARCOMA. SUPERVISOR: JAN PA BAAK.

 2012 PHD. ANE CECILIE D MUNK. MOLECULAR BIOMARKERS, HUMAN PAPILLOMAVIRUS -GENOTYPES AND CLINICAL FACTORS IN REGRESSION PREDICTION OF CERVICAL INTRAEPITHELIAL NEOPLASIA GRADES 2-3. SUPERVISOR: SUPERVISOR: JAN PA BAAK, EMIEL AM JANSSEN

2011 PHD. EINAR GUDLAUGSSON. PROLIFERATION, LYMPH VESSEL INVASION AND HISTOLOGIC TYPE AS PROGNOSTIC FACTORS IN LYMPH NODE NEGATIVE BREAST CANCER. SUPERVISOR: JAN PA BAAK, EMIEL AM JANSSEN

2011 PHD. KAI ERIK ULEBERG. PROTEOMIC ANALYSIS OF PROTEINS SECRETED BY BIOPSIES CONTAINING CIN 2-3 LESIONS. SUPERVISOR: JAN PA BAAK, EMIEL AM JANSSEN, ANNE HJELLE

2011 PHD. IRENE TVEITERÅS ØVESTAD. EVALUATION OF METHODS FOR THE DETECTION OF PERSISTENT AND REGRESSIVE CIN 2-3 LESIONS. SUPERVISOR: JAN PA BAAK.

2011 PHD. ANITA STEINBAKK. PROGNOSTIC BIOMARKERS IN ENDOMETRIOID ENDOMETRIAL NEOPLASIA. SUPERVISOR: JAN PA BAAK.

2011 PHD. HUI ZHANG. DAX-1 AND APOLIPOPROTEIN D IN BREAST CANCER. SUPERVISORS: JAN PA BAAK, EMIEL AM JANSSEN, HÅVARD SØILAND.

2009 PHD. IVAR SKALAND PROLIFERATION IN BREAST CANCER - IMMUNO HISTOCHEMISTRY AND DIGITAL IMAGE ANALYSIS. SUPERVISOR: JAN P.A. BAAK

2008 PHD. HÅVARD SØILAND. APOLIPOPROTEIN D AND ANDROGEN RECEPTOR IN BREAST CANCER - DETERMINATION METHODS AND ASPECTS OF PROGNOSTICATION. SUPERVISORS: JON ARNE SØREIDE, JAN BAAK, HARTWIG KØRNER

 2007 PHD. KJETIL SØREIDE. METACHRONOUS AND RECURRENT CANCER DEVELOPMENT IN COLORECTAL NEOPLASIA: CLINICAL ASPECTS, MOLECULAR BIOMARKERS AND PROTEOMIC IN SURVEILLANCE AND RISK. SUPERVISOR: JAN BAAK, HARTWIG KØRNER

2007 PHD. EMIEL JANSSEN. PROLIFERATION AND MOLECULAR FACTORS IN LYMPH NODE NEGATIVE BREAST CANCER. SUPERVISOR: JAN BAAK

2004 PHD. MARCO G. BOL. RECURRENCE AND PROGRESSION IN TaT1 UROTHELIAL CELL CARCINOMAS OF THE URINARY BLADDER. SUPERVISOR: JAN P.A.BAAK
(utgår fra Free university of Amsterdam)

2003 Arnold-Jan Krüse
Quantitative biomarkers to identify low and high risk early CIN lesions.
12. desember 2003 . Veilder Prof. Dr. Jan P.A. Baak